Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1D222-26). We employs the Lentivirus (CMV-Cy2-c-Jun-HindIII) vector components and the SynExpress system of the exons Inversion/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1D222-26
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy2
Promoter
CMV
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.95
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.